# The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events

> **NCT01052948** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 86939 (actual)

## Conditions studied

- Parkinson's Disease
- Hyperprolactinemia

## Interventions

- **OTHER:** Retrospective study-
- **OTHER:** Retrospective study-
- **OTHER:** Retrospective study-
- **OTHER:** Retrospective study-

## Key facts

- **NCT ID:** NCT01052948
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 86939 (ACTUAL)
- **Last updated:** 2011-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052948, "The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01052948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*